Literature DB >> 18644982

Increased Rac1b expression sustains colorectal tumor cell survival.

Paulo Matos1, Peter Jordan.   

Abstract

The small GTPase Rac1 can stimulate various signaling pathways that contribute to cell transformation. In particular, the activation of the NFkappaB transcription factor initiates an antiapoptotic response and promotes cell cycle progression through increased cyclin D1 expression. As a potential oncogenic mechanism to up-regulate this pathway, the overexpression of the Rac1b splicing variant was reported in some colorectal tumors. Rac1b exists predominantly in the active GTP-bound state and selectively promotes the pathway leading to NFkappaB activation. Here, we studied the role of endogenous Rac1b in colorectal cancer cells. We found that depletion of Rac1b by small interfering RNAs inhibited endogenous NFkappaB activation and reduced cell viability to 50% within 48 hours. This reduction was due to increased apoptosis, although a reduced G(1)-S progression rate was also observed. These data show, for the first time, that colorectal cells expressing alternative spliced Rac1b also depend on Rac1b signaling to sustain their survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644982     DOI: 10.1158/1541-7786.MCR-08-0008

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  34 in total

1.  Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma.

Authors:  Christine Mehner; Erin Miller; Davitte Khauv; Aziza Nassar; Ann L Oberg; William R Bamlet; Lizhi Zhang; Jens Waldmann; Evette S Radisky; Howard C Crawford; Derek C Radisky
Journal:  Mol Cancer Res       Date:  2014-05-21       Impact factor: 5.852

Review 2.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

3.  Perturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b.

Authors:  Anjaruwee S Nimnual; Laura J Taylor; Marian Nyako; Hao-Hsuan Jeng; Dafna Bar-Sagi
Journal:  Small GTPases       Date:  2010-09

Review 4.  The diverse roles of Rac signaling in tumorigenesis.

Authors:  Natalie A Mack; Helen J Whalley; Sonia Castillo-Lluva; Angeliki Malliri
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

5.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

Review 6.  Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

Authors:  A Sveen; S Kilpinen; A Ruusulehto; R A Lothe; R I Skotheim
Journal:  Oncogene       Date:  2015-08-24       Impact factor: 9.867

7.  Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.

Authors:  Federico Pelisch; Davitte Khauv; Guillermo Risso; Melody Stallings-Mann; Matías Blaustein; Leandro Quadrana; Derek C Radisky; Anabella Srebrow
Journal:  J Cell Biochem       Date:  2012-07       Impact factor: 4.429

8.  The 19-amino acid insertion in the tumor-associated splice isoform Rac1b confers specific binding to p120 catenin.

Authors:  Lidiya Orlichenko; Rory Geyer; Masahiro Yanagisawa; Davitte Khauv; Evette S Radisky; Panos Z Anastasiadis; Derek C Radisky
Journal:  J Biol Chem       Date:  2010-04-15       Impact factor: 5.157

9.  The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression.

Authors:  Larissa Kotelevets; Francine Walker; Godefroy Mamadou; Thérèse Lehy; Peter Jordan; Eric Chastre
Journal:  Oncogene       Date:  2018-07-09       Impact factor: 9.867

10.  Ibuprofen inhibits colitis-induced overexpression of tumor-related Rac1b.

Authors:  Paulo Matos; Larissa Kotelevets; Vania Goncalves; Andreai F A Henriques; Andreia Henriques; Philippe Zerbib; Mary Pat Moyer; Eric Chastre; Peter Jordan
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.